Lung Cancer Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Lung Cancer Treatment Market Growth and is Segmented by Disease Type (Non-small Cell Lung Cancer [NSCLC] and Small Cell Lung Cancer [SCLC]), Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, and Other Treatments), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The value is provided in terms of (USD million) for all the above segments.

Lung Cancer Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Lung Cancer Therapeutics Industry Overview

The lung cancer therapeutics market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known including AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Pfizer Inc., Amgen Inc., and Novartis AG, among others.

Lung Cancer Therapeutics Market Leaders

  1. AstraZeneca

  2. Boehringer Ingelheim

  3. Bristol-Myers Squibb Company

  4. Novartis AG

  5. Eli Lilly and Company

  6. *Disclaimer: Major Players sorted in no particular order
Lung Cancer Therapeutics Market Concentration